norethindrone has been researched along with Polycystic Ovary Syndrome in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (65.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 1 (5.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bordi, G; Caserta, D; Mallozzi, M; Matteucci, E; Moscarini, M; Ralli, E | 1 |
Agarwal, S; Dhuan, J; Gahlaut, PS; Rajput, R | 1 |
Russo, P; Trimarchi, CP | 1 |
BORY, R; CAPLIER, P | 1 |
MAGGIOLO, J | 1 |
Li, XZ; Zhou, XT | 1 |
Hicks, B; Raj, MH; Raj, SG; Sloan, CS; Talbert, LM | 1 |
Ditkoff, EC; Levin, JH; Lobo, RA; Paul, WL | 1 |
Arner, P; Bergqvist, A; Carlström, K; Ek, I; Reynisdottir, S; Wahrenberg, H | 1 |
Sloan, C; Talbert, LM | 1 |
Andersen, RN; Givens, JR; Umstot, ES; Wiser, WL | 1 |
Alekseeva, ML; Alieva, EA; Fanchenko, ND; Korsakov, SG; Novikov, EA | 1 |
Afonina, LI; Ataniiazova, OA; Orlova, VG; Smetnik, VP | 1 |
Givens, JR; Goodman, RC | 1 |
Andersen, RN; Coleman, SA; Fish, SA; Givens, JR; Kerber, IJ; Wiser, WL | 1 |
Easterling, WE; Potter, HD; Talbert, LM | 1 |
Daane, TA; Dignam, WJ; Frankland, MV; Parlow, AF; Simmer, HH | 1 |
Andersen, RN; Fish, SA; Givens, JR; Wiser, WL | 1 |
Jaffe, RB; Midgley, AR | 1 |
Decourt, J; Jayle, MF; Louchart, J; Mauvais-Jarvis, P; Truffert, J | 1 |
3 review(s) available for norethindrone and Polycystic Ovary Syndrome
Article | Year |
---|---|
Central venous sinus thrombosis in a young woman taking norethindrone acetate for dysfunctional uterine bleeding: case report and review of literature.
Topics: Contraceptives, Oral, Synthetic; Female; Heparin, Low-Molecular-Weight; Humans; Hyperhomocysteinemia; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Menorrhagia; Norethindrone; Nutrition Disorders; Polycystic Ovary Syndrome; Sinus Thrombosis, Intracranial; Treatment Outcome; Warfarin; Young Adult | 2008 |
[GYNECOLOGY].
Topics: Abortion, Threatened; Ascites; Capillary Resistance; Endometriosis; Estriol; Estrogens; Female; Genital Neoplasms, Female; Glycoside Hydrolases; Gold Isotopes; Gonadal Steroid Hormones; Gonadotropins; Gynecology; Humans; Menopause; Neoplasms; Norethindrone; Norethynodrel; Ovarian Neoplasms; Polycystic Ovary Syndrome; Pregnancy; Pregnanediol; Progesterone; Progestins; Uterine Prolapse | 1963 |
Current status of human gonadotropin radioimmunoassay.
Topics: Chorionic Gonadotropin; Clomiphene; Dimethisterone; Dydrogesterone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Intrauterine Devices; Luteinizing Hormone; Male; Menstruation; Norethindrone; Ovulation; Polycystic Ovary Syndrome; Pregnanediol; Radioimmunoassay | 1969 |
1 trial(s) available for norethindrone and Polycystic Ovary Syndrome
Article | Year |
---|---|
Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.
Topics: Adipocytes; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Diet, Reducing; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Lipolysis; Norethindrone; Obesity; Polycystic Ovary Syndrome; Radioligand Assay; Sympathetic Nervous System; Weight Loss | 1999 |
16 other study(ies) available for norethindrone and Polycystic Ovary Syndrome
Article | Year |
---|---|
A 29-year-old woman with complex atypical hyperplasia and polycystic ovary syndrome: a challenging issue.
Topics: Adult; Endometrial Hyperplasia; Female; Fertility Preservation; Humans; Norethindrone; Norethindrone Acetate; Polycystic Ovary Syndrome | 2014 |
Cyclic estrogen-progestin hormone therapy as a new therapeutic approach in the treatment of functional alterations of the hypothalamus-pituitary-ovary axis: case reports.
Topics: Adenoma; Adult; Amenorrhea; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Feedback; Female; Humans; Hypogonadism; Hypothalamus; Norethindrone; Norethindrone Acetate; Ovary; Pituitary Gland; Pituitary Neoplasms; Polycystic Ovary Syndrome | 2002 |
[DRUG THERAPY OF HIRSUTISM].
Topics: Adrenal Hyperplasia, Congenital; Adrenogenital Syndrome; Cushing Syndrome; Drug Therapy; Ethinyl Estradiol; Female; Hirsutism; Humans; Hypertrichosis; Norethindrone; Polycystic Ovary Syndrome | 1964 |
Study of nucleolar organizer in women with galactorrhea, or polycystic ovaries, or using oral contraceptive.
Topics: Adult; Contraceptives, Oral; Female; Galactorrhea; Humans; Lactation Disorders; Lymphocytes; Norethindrone; Nucleolus Organizer Region; Polycystic Ovary Syndrome; Pregnancy; RNA, Ribosomal; Silver; Staining and Labeling; Transcription, Genetic | 1983 |
Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with polycystic ovary syndrome.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norethindrone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1982 |
Time-resolved fluoroimmunoassay compared with radioimmunoassay of luteinizing hormone.
Topics: Adult; Evaluation Studies as Topic; Female; Fluoroimmunoassay; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Norethindrone; Polycystic Ovary Syndrome; Pulsatile Flow; Radioimmunoassay; Reference Values; Time Factors | 1993 |
The effect of a low-dose oral contraceptive on serum testosterone levels in polycystic ovary disease.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norethindrone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1979 |
Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease.
Topics: Carrier Proteins; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Mestranol; Norethindrone; Polycystic Ovary Syndrome; Prednisone; Protein Binding; Testosterone; Thyroxine; Time Factors | 1976 |
[Pulsed secretion of gonadotropins in polycystic ovary syndrome].
Topics: Adult; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Luteinizing Hormone; Norethindrone; Polycystic Ovary Syndrome; Time Factors | 1991 |
[Polycystic ovary syndrome with excess of prolactin].
Topics: Adult; Bromocriptine; Clomiphene; Dehydroepiandrosterone; Dexamethasone; Estrogens; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Norethindrone; Polycystic Ovary Syndrome; Prolactin | 1990 |
Hirsutism and polycystic ovary syndrome.
Topics: Adult; Androgens; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Insulin Resistance; Luteinizing Hormone; Mestranol; Norethindrone; Polycystic Ovary Syndrome | 1986 |
Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.
Topics: 17-Ketosteroids; Acanthosis Nigricans; Adolescent; Adrenocorticotropic Hormone; Androstenedione; Chorionic Gonadotropin; Dexamethasone; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Mestranol; Norethindrone; Ovarian Neoplasms; Polycystic Ovary Syndrome; Testosterone; Thecoma | 1974 |
Serum testosterone levels in the polycystic ovary syndrome. Effect of an estrogen-progestin on protein binding of testosterone.
Topics: Blood Proteins; Chromatography; Contraceptives, Oral, Synthetic; Female; Humans; Mestranol; Norethindrone; Polycystic Ovary Syndrome; Protein Binding; Testosterone; Tritium | 1974 |
Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
Topics: Adult; Androstenedione; Diethylstilbestrol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Menstruation Disturbances; Norethindrone; Ovary; Polycystic Ovary Syndrome; Testosterone | 1973 |
Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Androstenedione; Female; Follicle Stimulating Hormone; Humans; Iodine Radioisotopes; Luteinizing Hormone; Mestranol; Norethindrone; Polycystic Ovary Syndrome; Radioimmunoassay; Testosterone; Time Factors | 1974 |
[In vivo studies on metabolism of androgens following administration of steroid inhibitors of ovulation. 1. Changes in the secretion of androgens and excretion of their metabolites in normal subjects and women with the Stein-Leventhal syndrome].
Topics: 17-Ketosteroids; Androgens; Dexamethasone; Female; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Lynestrenol; Male; Mestranol; Norethindrone; Polycystic Ovary Syndrome; Testis; Testosterone; Urine | 1965 |